Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
Physics in Medicine and Biology|January 7, 2015
The absorbed dose to blood from blood-borne activityH Hänscheid, M Fernández, M Lassmann
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 5, 2020
Multicentre Trials on Standardised Quantitative Imaging and Dosimetry for Radionuclide TherapiesM Lassmann, U Eberlein, J Tran-Gia
European Journal of Nuclear Medicine and Molecular Imaging|August 28, 2010
EANM Dosimetry Committee guidance document: good practice of clinical dosimetry reportingM Lassmann, C Chiesa, G Flux, et al.
Physics in Medicine and Biology|March 6, 2014
Self-irradiation of the blood from selected nuclides in nuclear medicineH Hänscheid, M Fernández, U Eberlein, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 25, 2008
The new EANM paediatric dosage card: additional notes with respect to F-18M Lassmann, L Biassoni, M Monsieurs, et al.
Nuklearmedizin. Nuclear Medicine|December 18, 2010
(131)I therapy in patients with benign thyroid disease does not conclusively lead to a higher risk of subsequent malignanciesF A Verburg, M Luster, M Lassmann, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|March 10, 2011
The use of dosimetry in the treatment of differentiated thyroid cancerM Lassmann, H Hänscheid, F A Verburg, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 10, 2016
Recommended administered activities for (68)Ga-labelled peptides in paediatric nuclear medicineJ Soares Machado, S Beykan, K Herrmann, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 5, 2007
The new EANM paediatric dosage cardM Lassmann, L Biassoni, M Monsieurs, et al.
Nuklearmedizin. Nuclear Medicine|May 30, 1998
[Measurement of incorporation in family members of radioiodine therapy patients after therapy of benign thyroid diseases]M Lassmann, H Hänscheid, L F Schelper, et al.
Pageof 6